Format

Send to

Choose Destination
J Am Coll Cardiol. 2019 Apr 16;73(14):1827-1845. doi: 10.1016/j.jacc.2019.01.041.

Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review.

Author information

1
Depression and Anxiety Center for Discovery and Treatment, Department of Psychiatry, and Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York.
2
TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Electronic address: https://twitter.com/AqamarMD.
3
Heart & Vascular Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: https://twitter.com/mvaduganathan.
4
Depression and Anxiety Center for Discovery and Treatment, Department of Psychiatry, and Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York; Office of the Dean, Icahn School of Medicine at Mount Sinai, New York, New York.
5
Depression and Anxiety Center for Discovery and Treatment, Department of Psychiatry, and Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: james.murrough@mssm.edu.

Abstract

Depression is a common problem in patients with cardiovascular disease (CVD) and is associated with increased mortality, excess disability, greater health care expenditures, and reduced quality of life. Depression is present in 1 of 5 patients with coronary artery disease, peripheral artery disease, and heart failure. Depression complicates the optimal management of CVD by worsening cardiovascular risk factors and decreasing adherence to healthy lifestyles and evidence-based medical therapies. As such, standardized screening pathways for depression in patients with CVD offer the potential for early identification and optimal management of depression to improve health outcomes. Unfortunately, the burden of depression in patients with CVD is under-recognized; as a result, screening and management strategies targeting depression have been poorly implemented in patients with CVD. In this review, the authors discuss a practical approach for the screening and management of depression in patients with CVD.

KEYWORDS:

antidepressant treatment; cardiovascular disease; depression; screening

PMID:
30975301
DOI:
10.1016/j.jacc.2019.01.041

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center